Mersch et al. investigated the risk of developing CRC in a group of 613 BRCA1 and 459 BRCA2 mutation carriers and found no statistically significant difference between carriers and non-carriers [71]. The gene discussed is BRCA1; the disease is colorectal carcinoma.